| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6962706 |
Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
Nov. 8, 2005 |
| 6951652 |
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
Oct. 4, 2005 |
| 6951653 |
Streptococcal C5a peptidase vaccine |
Oct. 4, 2005 |
| 6949246 |
Compounds and methods for diagnosis of tuberculosis |
Sep. 27, 2005 |
| 6946132 |
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
Sep. 20, 2005 |
| 6942861 |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
Sep. 13, 2005 |
| 6939548 |
Methods to produce high levels of C. difficile toxins |
Sep. 6, 2005 |
| 6936250 |
Vaccines absorbable by the transmucosal way |
Aug. 30, 2005 |
| 6936258 |
Staphylococcus antigen and vaccine |
Aug. 30, 2005 |
| 6936261 |
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
Aug. 30, 2005 |
| 6936262 |
LktA deletion mutant of P. haemolytica |
Aug. 30, 2005 |
| 6936263 |
Th1 inducing natural adjuvant for heterologous antigens |
Aug. 30, 2005 |
| 6936447 |
Autoinducer molecule |
Aug. 30, 2005 |
| 6929794 |
IL-12 as an adjuvant for Bordetella pertussis vaccines |
Aug. 16, 2005 |
| 6929798 |
Compositions and methods for treatment of microbial infections |
Aug. 16, 2005 |
| 6929799 |
D-alanine racemase mutants of mycobacteria and uses therefore |
Aug. 16, 2005 |
| 6923958 |
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof |
Aug. 2, 2005 |
| 6923963 |
Diagnosis of ehrlichia canis and ehrlichia chaffeensis |
Aug. 2, 2005 |
| 6924118 |
Recombinant intracellular pathogen immunogenic compositions and methods for use |
Aug. 2, 2005 |
| 6921536 |
Lawsonia intracellularis vaccine |
Jul. 26, 2005 |
| 6921537 |
Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci |
Jul. 26, 2005 |
| 6921538 |
Therapeutic treatments for neuropsychiatric disorders |
Jul. 26, 2005 |
| 6916478 |
Vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
Jul. 12, 2005 |
| 6913753 |
Incapacitated whole-cell immunogenic bacterial compositions |
Jul. 5, 2005 |
| 6913754 |
Renibacterium salmoninarum vaccine |
Jul. 5, 2005 |
| 6913756 |
Monoclonal antibodies specific for anthrax and peptides derived from the antibodies thereof |
Jul. 5, 2005 |
| 6908619 |
Camp factor of streptococcus uberis |
Jun. 21, 2005 |
| 6908739 |
Diagnostic assays for detection of Giardia lamblia |
Jun. 21, 2005 |
| 6908994 |
Collagen-binding proteins from enterococcal bacteria |
Jun. 21, 2005 |
| 6905670 |
Methods of screening compounds useful for prevention of infection or pathogenicity |
Jun. 14, 2005 |
| 6905691 |
Vaccines containing attenuated bacteria |
Jun. 14, 2005 |
| 6902736 |
Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
Jun. 7, 2005 |
| 6903184 |
Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
Jun. 7, 2005 |
| 6896887 |
Bacterial ghosts provided with antigens |
May. 24, 2005 |
| 6896888 |
Treatment of papilloma virus infection using a mycobacterium |
May. 24, 2005 |
| 6893640 |
Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
May. 17, 2005 |
| 6887480 |
Streptococcus pneumoniae proteins and vaccines |
May. 3, 2005 |
| 6887481 |
Bacterial-derived molecules and therapeutic and diagnostic uses therefor |
May. 3, 2005 |
| 6887482 |
Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins |
May. 3, 2005 |
| 6887483 |
Non-toxic mutants of pathogenic gram-negative bacteria |
May. 3, 2005 |
| 6884423 |
Antimicrobial histone H1 compositions, kits, and methods of use thereof |
Apr. 26, 2005 |
| 6881410 |
Treatment of E. faecium infection |
Apr. 19, 2005 |
| 6881411 |
Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
Apr. 19, 2005 |
| 6881412 |
Modified live Flavobacterium columnare against columnaris disease in fish |
Apr. 19, 2005 |
| 6878377 |
Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system |
Apr. 12, 2005 |
| 6878816 |
Vmp-like sequences of pathogenic Borrelia |
Apr. 12, 2005 |
| 6875435 |
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
Apr. 5, 2005 |
| 6872394 |
Non-toxic immune stimulating enterotoxin compositions |
Mar. 29, 2005 |
| 6872397 |
Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B |
Mar. 29, 2005 |
| 6872542 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Mar. 29, 2005 |
|
|
|
